F 0605
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Prevent the use of unnecessary psychotropic medications or use medications that may restrain a resident's
ability to function.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
clinical record review and staff interviews it was determined that the facility failed to ensure that one
resident out of five sampled was free of chemical restraints used to most readily control the resident's
behavior and not required to treat the resident's medical symptoms (Resident B1).
Findings include:
A review of Resident B1's clinical record revealed that the resident was admitted to the facility on [DATE],
with diagnoses that included unspecified dementia (a group of symptoms that affects memory, thinking and
interferes with daily life), unspecified psychosis (is the term for a collection of symptoms that happen when
a person has a disconnection from reality and can occur due to different mental and physical conditions),
and insomnia.
An annual Minimum Data Set assessment (a federally mandated standardized assessment completed
periodically to plan resident care) dated May 8, 2024, indicated that the resident was severely cognitively
impaired with a BIMS (brief interview to assess cognitive status) score of 00 (00-07 represents severe
cognitive impairment) and that the resident was independent with ambulation. Section E0900
Wandering-Presence and Frequency: indicated that the resident displayed wandering behavior daily.
Section E1000 Wandering - Impact: indicated that the resident's wandering significantly intruded on the
privacy of activities of others.
Review of physician's order dated May 24, 2024, revealed an order for Risperdal (risperidone) tablet; 0.5
mg (an antipsychotic medication used to treat certain mental/mood disorders). Special instruction included
to document behaviors daily, twice a day at 9:00 AM and 5:00 PM.
Review of the Medication Administration Record for daily behavioral tracking for June 2024 and July 2024,
revealed no documented evidence that Risperdal was causing adverse side effects.
Review of nurses' and life enrichment notes dated from June 4, 2024, though July 30, 2024, revealed
Resident B1 exhibited wandering behaviors throughout the facility, picking up objects (such as wet floor
signs) and carrying them around. He required constant redirection, which was not always successful. It was
noted that he could become aggressive towards staff.
A nurses note dated June 17, 2024, at 4:29 PM revealed that the resident was ambulating around the
facility but was leaning forward which was not his norm. MD notified and ordered a spinal X-ray.
A nurses note dated June 18, 2024 at 12:04 AM revealed the resident was ambulating in the hallway
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
395493
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395493
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/01/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Julia Ribaudo Extended Care Center
1404 Golf Park Drive
Lake Ariel, PA 18436
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0605
Level of Harm - Minimal harm
or potential for actual harm
partially hunched over and drooling . A wheelchair was provided and a therapy referral was sent due to the
resident's need for wheelchair use.
Nurses note dated June 18, 2024 at 2:26 PM revealed the resident was seated in the wheelchair with not
much walking today.
Residents Affected - Few
A nurse practitioner note dated June 20, 2024, revealed a reassessment was conducted due to staff's
reports of the resident's new increased confusion and being slouched over in his chair. New orders for a
urinalysis (UA), culture and sensitivity, urology consult and CT scan of the head.
A nurses note dated July 4, 2024, at 4:54 PM revealed the UA results were negative.
A social service note dated July 11, 2024 at 6:25 PM revealed the IDT team met to discuss how Resident
B1 was doing on Risperdal. It was determined he was doing well. He remained on 15-minute checks for
behavior monitoring . He continued to wander hallways. Social Worker spoke to guardian about locked
secure units.
A nurses note dated July 13, 2024, at 1:09 AM revealed the resident had a fall in B Hall. No injuries were
noted.
A nurses note dated July 13, 2024 at 7:15 PM revealed the resident had another fall on C hall. No injuries
were noted.
A nurses note dated July 16, 2024 at 1:38 PM revealed an order from the MD (physician) for STAT
(immediate) urine test.
A nurses note dated July 17, 2024, at 10:00 AM revealed that the lab called the facility and informed them
that the resident's urine sample could not be processed because the urine was in in a vial and not a
specimen cup. CRNP (certified registered nurse practitioner) gave a new order for the urine to be collected
via a straight catheter for a drug screen and Benadryl level.
A nurses note dated July 17, 2024, at 3:16 PM revealed the resident was up walking around, leaned over at
times, and was able to sit in wheelchair for some time.
A CRNP progress note dated July 26, 2024, revealed that the urine drug screen was ordered on July 16,
2024, due to staff's reports of the resident drooling and being hunched over. The specimen was collected
on July 16, 2024, but not processed due to it being in the incorrect specimen container. Resident with a
face-to-face assessment on July 17, 2024, and noted to be drooling, hunched over, and slower to respond
than normal. He had falls on July 12, 2024, and July 13, 2024. A urine drug screen and Benadryl level was
ordered. Results of drug screen were received today and his urine was positive for diphenhydramine
(Benadryl) for which he is not prescribed and was not previously prescribed. The CRNP discussed the
findings with the facility leadership. Spoke with lab-Benadryl level still being processed and will be provided
once available. Resident observed earlier today- he is ambulating ad lib (freely) around the facility upright
without an assistive device. No drooling observed. The urine was negative for amphetamine, barbiturate,
[NAME], THC, cocaine, meth, opiates, pcp, ethanol. ID screen positive for acetaminophen, risperidone,
citalopram, diphenhydramine. He is on Tylenol, and risperidone. He had been on escitalopram which was
discontinued on July 10, 2024. As above, he had not been ordered Benadryl or any medication containing
the same.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395493
If continuation sheet
Page 2 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395493
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/01/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Julia Ribaudo Extended Care Center
1404 Golf Park Drive
Lake Ariel, PA 18436
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0605
Level of Harm - Minimal harm
or potential for actual harm
Review of the urine results labeled Reference Tests dated as verified July 29, 2024, revealed
concentrations of diphenhydramine between [PHONE NUMBER] ng/ml were found in the urine.
Review of an email communication from the CRNP to the Nursing Home Administrator dated July 29, 2024
at 11:39 AM revealed the following was communicated
Residents Affected - Few
In June, XXX (Resident B1) was noted to have increased confusion, drooling, hunched over, using a
wheelchair. Symptoms were not consistent but intermittent. Staff concerned that it may have been
risperidone causing symptoms- he had been on risperidone and would expect that if he had symptoms
from antipsychotic, it would be consistent. Labs and urine were done. Miraculously he didn't have any
symptoms like this for several weeks. On 7/16/24, I was informed by staff that he was off again and
something was not right. I ordered urine drug screen. Unfortunately, specimen was in wrong container and
not processed. On 7/17/24, I was in facility and went to see resident. He was drooling, sitting in wheelchair,
and extremely slow to respond to me. He was also noted to have 2 recent falls. There was no specific
neurological deficit, but he seemed off from his baseline. Because it's intermittent, I was concerned that he
may have drugs in his system that he shouldn't have, I ordered a drug screen including Benadryl level. Over
my career, I have hard numerous horror stories of elderly residents being given Benadryl without orders. I
ordered test to rule out any other reason for his intermittent increased confusion and intermittent functional
decline. Signed by the CRNP
According to the Merck Manual (comprehensive medical reference guide), diphenhydramine (Benadryl) is
used for the prevention and treatment of allergic or hypersensitivity reactions. It is also used for treating
symptoms associated with allergic rhinitis or the common cold and for cough caused by minor throat and
bronchial irritation. Adverse reactions, or side effects, of this medication are asthenia (weakness or lack of
energy), confusion, dizziness, drowsiness, fatigue, headache, and psychomotor impairment (slowing down
of thoughts and physical movements).
Interview with Employee 1 (licensed practical nurse) and Employee 2 (licensed practical nurses) on August
1, 2024 revealed Resident B1 consistently exhibited behaviors of being up all day and up all night. They
reported that he is constantly wandering the hallways and does laps around the facility. They stated that he
does not have family who visits or anyone who might bring him drugs or items from outside the facility.
Review of the resident's care plan for the problem of behavioral symptoms dated April 14, 2024, identified
that the resident has physical behavioral symptoms toward others (e.g. hitting, kicking, pushing, scratching,
abusing others sexually). The identified goal was that the resident will not harm others secondary to
physically abusive behavior. The care plan interventions included paired care for safety, assess whether the
behavior endangers the resident and/or others, avoid power struggles with resident, maintain a calm
environment and approach, obtain psych consult/psychosocial therapy as needed, offer one step verbal
directions for tasks, allow extra time to process information and provide consistent staff as much as
possible.
Continued review identified another problem category, dated May 17, 2024, of Cognitive loss/Dementia
indicating that the resident was at risk for elopement, dementia, and wandering. The identified goal was that
the resident will not leave the facility/building unattended. Interventions included use of a wander guard
(bracelet worn that triggers an alarm when approaching doors), calmly redirect from exit doors by offering
toileting and reminder of mealtimes, medications as ordered, and notify physician and responsible party of
exiting behavior. The resident's care plan did not include the use of the administration of Benadryl or any
medications containing diphenhydramine.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395493
If continuation sheet
Page 3 of 4
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
395493
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
08/01/2024
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Julia Ribaudo Extended Care Center
1404 Golf Park Drive
Lake Ariel, PA 18436
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0605
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
At the time of the survey ending August 1, 2024, there was no documented evidence of a physician order
for the administration of Benadryl to Resident B1.
Interview with the Nursing Home Administrator (NHA) on August 1, 2024, verified that Resident B1 did not
have a physician's order for Benadryl but received the drug during his stay at the facility. She confirmed that
during the period of time when diphenhydramine showed up in his urine results, the resident appeared
more sedated, and was not exhibiting his usual behavioral symptoms. The facility's follow up to the lab
results concluded that a staff member in the facility had given the resident Benadryl to most readily control
the resident's behaviors for staff convenience, but the perpetrator was not identified as of the time of the
survey ending August 1, 2024.
28 Pa. Code 211.12(c)(d)(1)(5) Nursing Services
28 Pa. Code 211.9(a)(1)(d) Pharmacy services
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
395493
If continuation sheet
Page 4 of 4